Dry Eye Tag

Health Notice: This article is for general educational purposes only and is not a substitute for medical or dental advice. Seek emergency care right away for swelling or redness around the eye with fever, pain when moving the eye, bulging of the eye, double vision, or sudden vision changes, or for facial swelling with a dental infection or trouble swallowing or breathing. Do not stop or change prescribed medications without talking with your healthcare provider.

Editorial Notice: This content is not specific medical advice. Providers and practices mentioned in this article are not warranted or endorsed by MedicalResearch.com or Eminent Domains Inc.

You usually think of your eyes and your teeth as separate parts of your health routine. One gets eye drops and vision tests; the other gets floss and cleanings. In practice, the line is thinner than it looks.

Inflammation, diabetes, infections, medication side effects, and autoimmune disease can affect both systems at once. If you pay attention to the overlap, you can catch problems earlier and ask better questions at both appointments.

MedicalResearch.com Interview with: Steven Woloshin, MD MS [caption id="attachment_25281" align="alignleft" width="180"]Steven Woloshin, MD Professor of The Dartmouth Institute Professor of Medicine Professor of Community and Family Medicine Dr. Steven Woloshin[/caption] Professor of The Dartmouth Institute Professor of Medicine Professor of Community and Family Medicine The Center for Medicine in the Media Dartmouth Institute for Health Policy and Clinical Practice Lebanon, New Hampshire MedicalResearch.com: What is the background for this study? What are the main findings? Response: There has been a lot of debate about the legal maneuvers (ie, transferring patents to the Mohawk Indians) Allergan has employed to delay marketing of generic alternatives to Restasis (cyclosporine ophthalmic emulsion 0.05%).   But there is a more fundamental question that has received little attention:  Does Restasis work?  It is not approved in the European Union, Australia or New Zealand where registration applications were "withdrawn prior to approval due to insufficient evidence of efficacy" in 2001.   Although Canada approved Restasis, its national health technology assessment unit, unconvinced of meaningful benefit, recommended Canada not pay for it - according to our research, no Canadian provincial or federal drug plan currently does.   Nevertheless, Americans have spent $8.8 billion in total sales between 2009 and 2015 on Restasis, including over $2.9 billion in public monies through Medicare Part D.

MedicalResearch.com Interview with: Dong Hyun Kim, M.D. Clinical assistant professor, Department of Ophthalmology, Gil Medical Center, Gachon University Incheon, Korea MedicalResearch.com: What is the background for this study? Dr. Kim: Air pollution is an important public health concern nowadays and ocular surface is continuously exposed to the outdoor air pollutants. Dry eye disease is a representative ocular surface...

MedicalResearch.com Interview with: Dr. Yang Liu MedicalResearch.com Interview with: Dr. Yang Liu Preceptor and David A. Sullivan, MS, PhD, FARVO Senior Scientist, Schepens Eye Research Institute Associate Professor, Department of Ophthalmology Harvard Medical School Boston, MA, USA  02114 Founder, Tear Film & Ocular Surface SocietyDr. David A. Sullivan, MS, PhD, FARVO Senior Scientist, Schepens Eye Research Institute, Associate Professor, Department of Ophthalmology Harvard Medical School Boston, MA, USA  02114 MedicalResearch.com: What is the main finding of the study? Answer: We discovered that azithromycin (AZM) can directly stimulate the function of human meibomian gland epithelial cells. Given this finding, it is possible that this antibiotic may prove beneficial as a treatment for meibomian gland dysfunction (MGD), which is the leading cause of dry eye disease in the world.